Company Overview
Pharmapro Healthcare Ltd is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Thursday 11 June 2020. Pharmapro Healthcare Ltd has been in business for 5 years and 9 months. The accounts status is micro entity and the accounts are next due on Tuesday 30 June 2026.
Registered Address

13 Montpelier Avenue, Bexley, Kent, DA5 3AP
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NamePHARMAPRO HEALTHCARE LTD
Company Number12661729
Registered Office Address13 Montpelier Avenue
 DA5 3AP
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date11/06/2020
Accounting Reference Date Day30
Accounting Reference Date Month9
Accounts Next Due Date30/06/2026
Accounts Last Made Up Date30/09/2024
Accounts Account CategoryMICRO ENTITY
Returns Next Due Date09/07/2021
Directors & Members
Parvathi Nallamchetty - Director
(British, 53 years old, born July 1973)
Appointed 24 October 2025
 Active
Kalvinder Ruprai - Director
(British, 57 years old, born July 1969)
Appointed 11 June 2020
 Active
Secretaries
No Secretaries Appointed
Other Company Directorships
Parvathi Nallamchetty
KUNZ THERAPEUTICS LTD
Kalvinder Ruprai
AK ROBERTSBRIDGE LIMITED
FINPROP LIMITED
FOR LOVE OF ANIMALS LTD
GARUSA SOLUTIONS U.K. LIMITED
HEARN DESIGN LIMITED
JSK PARTITIONS LTD
MABARA LABS LIMITED
RUDIPHARM (AUSTRALIA) LTD
RUDIPHARM LIMITED
RUPRAI GROUP LIMITED
Balance Sheet Unlock full report
Accounts Date 30-Sep-2024 30-Sep-2022 30-Sep-2021
Balance Sheet
Fixed Assets - - -
Current Assets - - -
Creditors Due Within One Year - - -
Working Cap - - -
Total Assets Less Current Liabilities - - -
Long-term Liabilities - - -
Net Assets 100 100 100
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 100 100 100
Common Size Financial Analysis Unlock full report
Accounts Date 30-Sep-2024 30-Sep-2022 30-Sep-2021
Tangible Fixed Assets - - -
Fixed Assets - - -
Stocks Inventory - - -
Debtors - - -
Cash Bank In Hand - - -
Current Assets - - -
Creditors Due Within One Year - - -
Net Current Assets Liabilities - - -
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds - - -
Capital Employed - - -
Total Assets Less Current Liabilities - - -
Financial Ratio Analysis Unlock full report
Accounts Date 30-Sep-2024 30-Sep-2022 30-Sep-2021
Liquidity Ratio 0.0 0.0 0.0
Solvency Ratio - - -
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 30-Sep-2024 30-Sep-2022 30-Sep-2021
Assets - - -
Debt - - -
Net Assets/Debt 100 100 100
It is not clear that the company was actively trading prior to the latest financial data filed. Examination of the full accounts may provide further information. If the company remains active on the company register it may have traded in the period since the date of the latest filed accounts. A full credit report may provide information relating to trade payment history and county court or court judgments if any.
Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around DA5 3AP
NORTH BRIDGE FUNDING LTD
C/O KISHENS LIMITED, 13 MONTPELIER AVENUE, BEXLEY, KENT, DA5 3AP
PRO HOMES LTD
C/O KISHENS LIMITED, 13 MONTPELIER AVENUE, BEXLEY, KENT, DA5 3AP
SR8 PROPERTIES LTD
C/O KISHENS LIMITED, 13 MONTPELIER AVENUE, BEXLEY, KENT, DA5 3AP
KEM PHYSIO LTD
19 Montpelier Avenue, Bexley, Kent, DA5 3AP
ERITH & BELVEDERE FOOTBALL CLUB LIMITED
39 HIGH STREET, ORPINGTON, DA5 3AP
GOMES PHOTOGRAPHY LIMITED
13 Montpelier Avenue, Bexley, Kent, DA5 3AP
SPOT BI LIMITED
3 Montpelier Avenue, Bexley, Kent, DA5 3AP
LLJ COMMERCE LIMITED
C/O Kishens Limited, 13 Montpelier Avenue, Bexley, Kent, DA5 3AP
MARLBOROUGH BAKERIES (1942) LIMITED
64 KIMMERIDGE ROAD, LONDON, DA5 3AP
ANDY MATTHEWS PICTURES LIMITED
3 Montpelier Avenue, Bexley, Kent, DA5 3AP
Document Filings
Confirmation statement made on 17 March 2026 with updates
Notification of Ruprai Group Ltd as a person with significant control on 31 January 2026
Termination of appointment of Parvathi Nallamchetty as a director on 31 January 2026
Cessation of Rudipharm (Australia) Ltd as a person with significant control on 31 January 2026
Cessation of Kunz Therapeutics Ltd as a person with significant control on 31 January 2026
Confirmation statement made on 24 October 2025 with updates
Appointment of Mrs Parvathi Nallamchetty as a director on 24 October 2025
Notification of Kunz Therapeutics Ltd as a person with significant control on 24 October 2025
Notification of Rudipharm (Australia) Ltd as a person with significant control on 24 October 2025
Cessation of Ruprai Group Limited as a person with significant control on 24 October 2025
Confirmation statement made on 16 August 2025 with no updates
Confirmation statement made on 16 August 2024 with no updates
Confirmation statement made on 16 August 2023 with no updates
Confirmation statement made on 16 August 2022 with updates
Notification of Ruprai Group Limited as a person with significant control on 7 July 2021
Cessation of Medpro Healthcare Ltd as a person with significant control on 7 July 2021
Confirmation statement made on 9 June 2022 with no updates
Confirmation statement made on 9 June 2021 with updates
Previous accounting period shortened from 30 June 2021 to 30 September 2020
Confirmation statement made on 4 October 2020 with updates
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free